Phenytoin Sodium

苯妥英钠

Report date: 2023/02/09 16:46:01
NME

Base Information

Drug NamePhenytoin Sodium
Drug Alias Name二苯乙内酰脲钠DintoinaDilantinOROS-PhenytoinEpanutin +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsStatus EpilepticusSeizuresEpilepsy
Global Approved IndicationsStatus EpilepticusSeizuresEpilepsy
Approved Indications in ChinaEpilepsy
Original Approved Country/TerritoryUnited States
Original Approved Date1956/03/01
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
China Registration ClassN/A

Develop Information

Active CompaniesHikma Farmaceutica, (Portugal) SaJiangsu Yongda Medical Co Ltd
Inactive CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
Active IndicationsEpilepsy
Inactive IndicationsStatus EpilepticusSeizures

Other Information

ATC CodeN03AB02
Related LinksWikipediaDrugBankKEGG